Follow
Yolanda Pires Afonso
Yolanda Pires Afonso
PhD in Biology
No verified email
Title
Cited by
Cited by
Year
Single‐cell transcriptomics reveals distinct inflammation‐induced microglia signatures
C Sousa, A Golebiewska, SK Poovathingal, T Kaoma, Y Pires‐Afonso, ...
EMBO reports 19 (11), e46171, 2018
2362018
Revealing and harnessing tumour-associated microglia/macrophage heterogeneity in glioblastoma
Y Pires-Afonso, SP Niclou, A Michelucci
International journal of molecular sciences 21 (3), 689, 2020
582020
Citraconate inhibits ACOD1 (IRG1) catalysis, reduces interferon responses and oxidative stress, and modulates inflammation and cell metabolism
F Chen, WAM Elgaher, M Winterhoff, K Büssow, FH Waqas, E Graner, ...
Nature Metabolism 4 (5), 534-546, 2022
522022
Protein phosphatase 1 regulates huntingtin exon 1 aggregation and toxicity
J Branco-Santos, F Herrera, GM Poças, Y Pires-Afonso, F Giorgini, ...
Human molecular genetics 26 (19), 3763-3775, 2017
372017
Single-cell transcriptomics and in situ morphological analyses reveal microglia heterogeneity across the nigrostriatal pathway
O Uriarte Huarte, D Kyriakis, T Heurtaux, Y Pires-Afonso, R Halder, ...
Frontiers in Immunology 12, 639613, 2021
352021
Elucidating tumour‐associated microglia/macrophage diversity along glioblastoma progression and under ACOD1 deficiency
Y Pires‐Afonso, A Muller, K Grzyb, A Oudin, YA Yabo, C Sousa, A Scafidi, ...
Molecular Oncology 16 (17), 3167-3191, 2022
112022
Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived …
YA Yabo, PM Moreno-Sanchez, Y Pires-Afonso, T Kaoma, B Nosirov, ...
bioRxiv, 2023
2023
OS05. 5. A Glioblastoma-instructed microglia transit to heterogeneous phenotypic states with dendritic cell-like features in patient tumors and patient-derived orthotopic …
YA Yabo, Y Pires-Afonso, PM Moreno-Sanchez, A Oudin, T Kaoma, ...
Neuro-Oncology 24 (Suppl 2), ii13, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–8